SHANGHAI HEARTCARE MEDICAL TECHNOLOGY CORPORATION LIMITED

Shanghai HeartCare Medical Technology Corporation Limited

Equities

6609

CNE100004MN5

Medical Equipment, Supplies & Distribution

Market Closed - Hong Kong S.E. Other stock markets 01:38:12 14/06/2024 pm IST			5-day change	1st Jan Change
17.02 ^HKD	+0.12%		+0.83%	-42.79%

28/03	Shanghai HeartCare Medical Technology Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Shanghai HeartCare Offloads Stake in Medical Device Developer Shenji Medical	MT

Shanghai HeartCare Medical Technology Corporation Limited Announces Resignation of Liu Yanbin as Non-Executive Director

December 10, 2021 at 07:51 pm IST

Shanghai HeartCare Medical Technology Corporation Limited announced that Mr. Liu Yanbin ("Mr. Liu") resigned as a non-executive Director with effect from December 10, 2021 due to his other personal commitments.

Latest news about Shanghai HeartCare Medical Technology Corporation Limited

Shanghai HeartCare Medical Technology Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2023	28/03	CI
Shanghai HeartCare Offloads Stake in Medical Device Developer Shenji Medical	12/12	MT
Shanghai Heartcare Medical Technology Corporation Limited Appoints Xue Zongyu as the Chairperson of the Supervisory Committee	17/11	CI
Shanghai Heartcare Medical Technology Corporation Limited Announces Board Changes	08/11	CI
Shanghai HeartCare Medical Technology Corporation Limited(SEHK:6609) dropped from S&P Global BMI Index	18/23/18	CI
HeartCare Medical Technology's Loss Narrows in H1	01/23/01	MT
Shanghai HeartCare Medical Technology Corporation Limited Reports Earnings Results for the Half Year Ended June 30, 2023	31/23/31	CI
Shanghai HeartCare Medical Technology Corporation Limited Announces Nomination Committee Changes	20/23/20	CI
Shanghai HeartCare Medical Technology Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2022	20/23/20	CI
Shanghai Heartcare Medical Technology Corporation Limited Appoints Chen Shaoxiong as A Non-Executive Director	09/22/09	CI
Shanghai Heartcare Medical Technology Corporation Limited Announces Resignation of Chen Gang as Non-Executive Director	31/22/31	CI
Shanghai HeartCare Medical Technology Corporation Limited Reports Earnings Results for the Half Year Ended June 30, 2022	31/22/31	CI
536,714 Unlisted Foreign Shares of Shanghai HeartCare Medical Technology Corporation Limited are subject to a Lock-Up Agreement Ending on 19-AUG-2022.	19/22/19	CI
6,731,890 Domestic Shares of Shanghai HeartCare Medical Technology Corporation Limited are subject to a Lock-Up Agreement Ending on 19-AUG-2022.	19/22/19	CI
24,963,954 H Shares of Shanghai HeartCare Medical Technology Corporation Limited are subject to a Lock-Up Agreement Ending on 19-AUG-2022.	19/22/19	CI
Shanghai Heartcare Medical Technology Corporation Limited Announces Resignation of Ouyang Xiangyu as Non-Executive Director	15/22/15	CI
Shanghai Heartcare Medical Technology Corporation Limited Appoints Wei Jiawei as an Executive Director	10/22/10	CI
Shanghai HeartCare Medical Technology Corporation Limited Voluntary Receives Approval from the National Medical Products Administration for registration application for LAA Occluder	28/22/28	CI
Shanghai Heartcare Medical Technology Corporation Limited Receives the Approvals from the National Medical Products Administration of the PRC for the Registration Applications for the Aspiration Catheter and Support Catheter	26/22/26	CI
Shanghai HeartCare Medical Technology Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2021	28/22/28	CI
Shanghai HeartCare Medical Technology Corporation Limited Announces Change of Principal Place of Business in Hong Kong	24/22/24	CI
Shanghai Heartcare Medical Technology Corporation Limited Announces Executive Changes	24/22/24	CI
Shanghai HeartCare Medical Technology Corporation Limited(SEHK:6609) added to S&P Global BMI Index	21/22/21	CI
Chinese Regulators OK HeartCare Medical's Registration Application for Neuro-Interventional Product	18/22/18	MT
Shanghai Heartcare Medical Technology Corporation Limited Announces Embolic Coil Received NMPA Approval	17/22/17	CI

Chart Shanghai HeartCare Medical Technology Corporation Limited

Duration

Period

Chart Shanghai HeartCare Medical Technology Corporation Limited

More charts

Company Profile

Shanghai HeartCare Medical Technology Corp Ltd is a China-based company engaged in the research and development of innovative neuro-interventional medical device. The Company's product portfolio includes both neuro-interventional and cardiac medical devices, and its main products are CaptorTM thrombectomy device (Captor) and left atrial appendage occluder. The Company's product portfolio extends from the treatment and prevention of ischemic stroke, including acute ischemic stroke and intracranial stenosis to the treatment of hemorrhagic stroke. The Company's other products include the balloon guiding catheter, the ExtraFlex distal access catheter and SupSelek microcatheter. The Company distributes its products within the domestic market.

Sector

Medical Equipment, Supplies & Distribution

Calendar

28/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Shanghai HeartCare Medical Technology Corporation Limited

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

15.81 CNY

Average target price

27.12 CNY

Spread / Average Target

+71.53%

Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
SHANGHAI HEARTCARE MEDICAL TECHNOLOGY CORPORATION LIMITED	-42.79%	83.1M
ABBOTT LABORATORIES	-5.81%	180B
MEDTRONIC PLC	-1.63%	106B
BECTON, DICKINSON AND COMPANY	-4.14%	67.55B
DEXCOM, INC.	-6.56%	46.11B
CENCORA, INC.	+13.22%	45.79B
HOYA CORPORATION	+6.13%	41.61B
METTLER-TOLEDO INTERNATIONAL, INC.	+19.93%	31.07B
TERUMO CORPORATION	+13.61%	24.77B
WEST PHARMACEUTICAL SERVICES, INC.	-5.36%	24.27B

Other Medical Equipment, Supplies & Distribution